A New Dawn in Oncology: FDA Approves Daraxonrasib, Doubling Survival in Metastatic Pancreatic Cancer
Executive Overview In a historic milestone for clinical oncology, the U.S. Food and Drug Administration (FDA) has granted accelerated approval…
